Revenue for the quarter grew 15% to ₹1,670 crore from ₹1,451.6 crore a year ago, reflecting improved demand across segments. Earnings before interest, tax, depreciation, and amortisation (EBITDA) increased 25.7% to ₹280 crore from ₹223 crore in the year-ago period, while operating margin expanded to 17% from 15.4%.
On a consolidated basis, total income stood at ₹1,759.64 crore for the quarter, while profit attributable to owners of the company came in at ₹210.15 crore.
Also read: Reliance Industries Q4 Results Live Updates: Stock down 1% ahead of earnings
For the full financial year ended March 31, 2026, consolidated revenue from operations rose to ₹6,273.54 crore from ₹5,583.35 crore in FY25. Profit after tax for the year increased to ₹689.39 crore from ₹498.83 crore in the previous year.
Segment-wise, the company’s performance was driven by both its Life Science Chemicals and Performance & Other Chemicals businesses, which reported steady growth during the quarter and the full year.
The Board of Directors has recommended a dividend of ₹30 per equity share for FY26, subject to approval by shareholders at the upcoming annual general meeting.
The company said its financial results were prepared in accordance with applicable accounting standards, with auditors issuing an unmodified opinion on both standalone and consolidated numbers.
Shares of the company are trading 1.70% up up at ₹6,841.50 as of 2.47 pm following the Q4 result announcement. The stock has gained about 12% in the last one month and nearly 10% in the last year.
